Murray Stewart, Tracy http://orcid.org/0000-0001-8679-6414
Desai, Apurva A.
Fitzgerald, Michael L.
Marton, Laurence J.
Casero, Robert A. Jr.
Funding for this research was provided by:
National Cancer Institute (R01CA204345, R01CA235863, R01CA51085)
Article History
Received: 24 March 2020
Accepted: 13 May 2020
First Online: 23 May 2020
Compliance with ethical standards
:
: During the development of PG-11047, in vitro and in vivo preclinical studies of PG-11047 and related analogs were funded in part by a gift to the laboratory of RAC by Cellgate, Inc., the previous owner of PG-11047.
: The trial was conducted in accordance with the IRB-approved protocol, the ethical principles of Good Clinical Practice, according to the ICH Harmonized Tripartite Guideline, and the Declaration of Helsinki.
: All participants provided written informed consent that was approved by the Institutional Review Board (IRB) of the University of Chicago.